Progress in using the drugs based on hydrobionts in treatment of respiratory viral infections and their complications

Abstract

The data of possibilities to use biologically active compounds, peptides and polysaccharides in particular, from sea urchins as potent sources of drugs are represented in the article. Their ability to act on the main chains of pathogenesis of the respiratory viral infections has been shown. So peptides and polysaccharides possess anti-inflammatory action due to inhibition of cyclooxygenase and inhibition of MAP kinase p38 phosphorylation, as well as antioxidant, immune correcting, antiviral and antibacterial effects. The progress in searching new drugs based on glycopeptides from sea urchins for treatment of respiratory tract infections and their complications are discussed.